Advertisement Pharmaceutical Business review - Page 11 of 5216 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 16, 2024

US FDA grants RMAT designation for Kyverna’s KYV-101

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for Kyverna Therapeutics’ chimeric antigen receptor (CAR) T-cell product candidate, KYV-101 for treating refractory stiff-person syndrome (SPS).

Continue
Till date, approximately 50 patients have been treated with KYV-101's CAR technology. Credit: Steve Buissinne from Pixabay.
July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

MSD intends to bolster its ophthalmology portfolio. Credit: Paul Diaconu from Pixabay.
July 12, 2024

Leqembi gains approval for Alzheimer’s treatment in Israel

Israel becomes the sixth territory to endorse the drug for Alzheimer's treatment after the US, Japan, China, South Korea, and Hong Kong. Credit: TioNegro14 from Pixabay.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Deals

Deals April 18, 2024

Biocon signs licensing and supply deal for diabetes drug in Brazil

Pharmaceutical Business Review

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Kindeva Drug Delivery acquires Summit Biosciences

Popular

  1. Cosette Pharmaceuticals acquires Ambien rights in US
  2. Amneal Pharmaceuticals launches ready-to-use injectable FOCINVEZ
  3. Adicet Bio’s ADI-270 receives FDA Fast Track Designation for kidney cancer treatment
  4. EU approves AstraZeneca’s Tagrisso combined with chemotherapy for EGFRm NSCLC
  5. Alembic receives tentative approval from USFDA for Ivosidenib Tablets

PRESS RELEASES

Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation